(MAS) Masco - Overview
Sector: Industrials | Industry: Building Products & Equipment | Exchange: NYSE (USA) | Market Cap: 13.569m USD | Total Return: 12.8% in 12m
Avg Turnover: 170M
EPS Trend: 79.2%
Qual. Beats: 1
Rev. Trend: -94.2%
Qual. Beats: 1
Warnings
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
Masco Corporation (NYSE: MAS) is a global manufacturer and distributor of home improvement and building products, operating primarily through two core segments: Plumbing Products and Decorative Architectural Products. Founded in 1929 and headquartered in Livonia, Michigan, the company manages a portfolio of established brands including Delta, Hansgrohe, Behr, and Kilz. Its distribution network spans home centers, online retailers, wholesalers, and professional contractors.
The company operates within the building products sector, where demand is heavily influenced by repair and remodel (R&R) activity rather than solely new home construction. Masco’s business model relies on maintaining strong brand equity to secure premium shelf space in major retail channels like The Home Depot. The Plumbing segment focuses on water delivery and wellness products, while the Decorative segment centers on coatings and hardware solutions.
Investors can review detailed financial metrics and historical performance for Masco on ValueRay to further their analysis. The company serves a diverse customer base ranging from individual DIY consumers to large-scale original equipment manufacturers.
- Existing home sales volume dictates demand for repair and remodel projects
- Raw material costs for copper and resins impact plumbing segment margins
- Behr paint exclusivity with Home Depot ties revenue to big-box retail traffic
- Consumer discretionary spending levels influence premium spa and decorative hardware sales
- Mortgage rate fluctuations drive residential construction and large-scale renovation activity
| Net Income: 837.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 1.51 > 1.0 |
| NWC/Revenue: 16.17% < 20% (prev 15.51%; Δ 0.66% < -1%) |
| CFO/TA 0.21 > 3% & CFO 1.10b > Net Income 837.0m |
| Net Debt (3.14b) to EBITDA (1.44b): 2.19 < 3 |
| Current Ratio: 1.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (202.9m) vs 12m ago -4.76% < -2% |
| Gross Margin: 35.41% > 18% (prev 0.36%; Δ 3.50k% > 0.5%) |
| Asset Turnover: 148.5% > 50% (prev 150.8%; Δ -2.30% > 0%) |
| Interest Coverage Ratio: 12.76 > 6 (EBITDA TTM 1.44b / Interest Expense TTM 101.0m) |
| A: 0.24 (Total Current Assets 2.90b - Total Current Liabilities 1.65b) / Total Assets 5.23b |
| B: -0.14 (Retained Earnings -722.0m / Total Assets 5.23b) |
| C: 0.25 (EBIT TTM 1.29b / Avg Total Assets 5.17b) |
| D: -0.05 (Book Value of Equity -242.0m / Total Liabilities 5.21b) |
| Altman-Z'' = 2.73 = A |
| DSRI: 1.05 (Receivables 1.32b/1.26b, Revenue 7.68b/7.70b) |
| GMI: 1.02 (GM 35.41% / 36.23%) |
| AQI: 1.20 (AQ_t 0.22 / AQ_t-1 0.18) |
| SGI: 1.00 (Revenue 7.68b / 7.70b) |
| TATA: -0.05 (NI 837.0m - CFO 1.10b) / TA 5.23b) |
| Beneish M = -2.90 (Cap -4..+1) = A |
As of May 30, 2026, the stock is trading at USD 70.25 with a total of 1,755,916 shares traded.
Over the past week, the price has changed by +5.12%,
over one month by -0.95%,
over three months by -1.44% and
over the past year by +12.79%.
Masco has received a consensus analysts rating of 3.63. Therefore, it is recommended to hold MAS.
- StrongBuy: 6
- Buy: 4
- Hold: 13
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 80.7 | 14.8% |
P/E Trailing = 16.6485
P/E Forward = 16.129
P/S = 1.767
P/B = 160.2462
P/EG = 1.6991
Revenue TTM = 7.68b USD
EBIT TTM = 1.29b USD
EBITDA TTM = 1.44b USD
Long Term Debt = 2.94b USD (from longTermDebt, last quarter)
Short Term Debt = 129.0m USD (from shortTermDebt, last quarter)
Debt = 3.53b USD (from shortLongTermDebtTotal, last quarter) + Leases 228.0m
Net Debt = 3.14b USD (calculated: Debt 3.53b - CCE 388.0m)
Enterprise Value = 16.7b USD (13.6b + Debt 3.53b - CCE 388.0m)
Interest Coverage Ratio = 12.76 (Ebit TTM 1.29b / Interest Expense TTM 101.0m)
EV/FCF = 17.72x (Enterprise Value 16.7b / FCF TTM 943.0m)
FCF Yield = 5.64% (FCF TTM 943.0m / Enterprise Value 16.7b)
FCF Margin = 12.28% (FCF TTM 943.0m / Revenue TTM 7.68b)
Net Margin = 10.90% (Net Income TTM 837.0m / Revenue TTM 7.68b)
Gross Margin = 35.41% ((Revenue TTM 7.68b - Cost of Revenue TTM 4.96b) / Revenue TTM)
Gross Margin QoQ = 35.77% (prev 33.69%)
Tobins Q-Ratio = 3.19 (Enterprise Value 16.7b / Total Assets 5.23b)
Interest Expense / Debt = 2.86% (Interest Expense 101.0m / Debt 3.53b)
Taxrate = 21.65% (63.0m / 291.0m)
NOPAT = 1.01b (EBIT 1.29b * (1 - 21.65%))
Current Ratio = 1.75 (Total Current Assets 2.90b / Total Current Liabilities 1.65b)
Debt / Equity = -14.59 (negative equity) (Debt 3.53b / totalStockholderEquity, last quarter -242.0m)
Debt / EBITDA = 2.19 (Net Debt 3.14b / EBITDA 1.44b)
Debt / FCF = 3.33 (Net Debt 3.14b / FCF TTM 943.0m)
Total Stockholder Equity = 37.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 16.19% (Net Income 837.0m / Total Assets 5.23b)
RoE = 110.2% (Net Income TTM 837.0m / Total Stockholder Equity 759.5m)
RoCE = 34.80% (EBIT 1.29b / Capital Employed (Equity 759.5m + L.T.Debt 2.94b))
RoIC = 27.23% (NOPAT 1.01b / Invested Capital 3.71b)
WACC = 8.33% (E(13.6b)/V(17.1b) * Re(9.92%) + D(3.53b)/V(17.1b) * Rd(2.86%) * (1-Tc(0.22)))
Discount Rate = 9.92% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.88 | Cagr: -4.31%
[DCF] Terminal Value 76.87% ; FCFF base≈903.0m ; Y1≈995.5m ; Y5≈1.27b
[DCF] Fair Price = 80.61 (EV 19.4b - Net Debt 3.14b = Equity 16.3b / Shares 201.7m; r=8.35% [WACC [floored]]; 5y FCF grow 11.86% → 2.50% )
EPS Correlation: 79.16 | EPS CAGR: 3.34% | SUE: 1.89 | # QB: 1
Revenue Correlation: -94.17 | Revenue CAGR: -2.55% | SUE: 2.99 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.31 | Chg30d=+0.66% | Revisions=+30% | Analysts=21
EPS next Quarter (2026-09-30): EPS=1.06 | Chg30d=-3.40% | Revisions=-55% | Analysts=21
EPS current Year (2026-12-31): EPS=4.27 | Chg30d=+2.16% | Revisions=+83% | GrowthEPS=+7.8% | GrowthRev=+2.7%
EPS next Year (2027-12-31): EPS=4.70 | Chg30d=+2.02% | Revisions=+80% | GrowthEPS=+10.1% | GrowthRev=+3.1%
[Analyst] Revisions Ratio: +83%